Influenza combinatorial antigen vaccine

Details Influenza combinatorial antigen vaccine Influenza combinatorial antigen vaccine

A - Human Necessities

61

K

A61K 39/145 (2006.01) A61P 31/16 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2627105

The present invention relates to a method of treating cancer in a subject in need thereof, by administering to a subject in need thereof a first amount of a histone deacetylase (HDAC) inhibitor or a pharmaceutically acceptable salt or hydrate thereof, and a second amount of an anti-cancer agent. The HDAC inhibitor and the anti-cancer agent may be administered to comprise therapeutically effective amounts. In various aspects, the effect of the HDAC inhibitor and the anti-cancer agent may be additive or synergistic.

La présente invention concerne un procédé de traitement anticancéreux d~un patient par administration d~une première quantité d~inhibiteur de la histone désacétylase (HDAC) ou d~un sel ou hydrate dudit inhibiteur pharmaceutiquement acceptable, puis d~une seconde quantité d~un agent anticancéreux. L~inhibiteur de HDAC et l~agent anticancéreux peuvent être administrés en des quantités efficaces sur le plan thérapeutique. Sous divers aspects, les effets de l~inhibiteur de HDAC et de l~agent anticancéreux peuvent se combiner de manière additive ou synergique.

Affiliated with

Also associated with

Rating

Influenza combinatorial antigen vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Influenza combinatorial antigen vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Influenza combinatorial antigen vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1740001